Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

Neurology

Volumn 53, Issue 5, 1999, Pages 922-926

  Kälviäinen, Reetta ^a   Nousiainen, I ^b   Mantyjarvi M ^b   Nikoskelainen, E ^b   Partanen, J ^b   Partanen, K ^b   Riekkinen Sr , P ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Antiepileptic drugs; Vigabatrin; Visual field defect

Indexed keywords

CARBAMAZEPINE; VIGABATRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MALE; PERIMETRY; PRIORITY JOURNAL; RISK ASSESSMENT; VISION TEST; VISUAL FIELD DEFECT;

EID: 0344118227     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.5.922     Document Type: Article

References (20)

1. Schechter PJ, Tranier Y, Jung MJ, Böhlen P. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic GABA and gamma-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 1977;45:319-328.
2. Eke T, Talbot, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:180-181.
3. Wong ICK, Mawer GE, Sander JWAS. Severe persistent visual constriction associated with vigabatrin. Reaction may be dose dependent. BMJ 1997;314:1693-1694.
4. Blackwell N, Hayllar J, Kelly G. Severe persistent visual constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing. BMJ 1997;314: 1694. Letter.
5. Harding GFA. Severe persistent visual constriction associated with vigabatrin. Four possible explanations exist. BMJ 1997; 314:1694. Letter.
6. Kramer G, Scollo-Lavizzari G, Jallon P, et al. Vigabatrin-associated bilateral concentric visual field defects in four patients. Epilepsia 1997;38(suppl 8):179.
7. Mackenzie R, Klistorner A. Severe persistent visual constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ 1998;316: 232. Letter.
8. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings. Neurology 1998;50:614-618.
9. Wilson EA, Brodie MJ. Severe persistent visual constriction associated with vigabatrin. Chronic refractory epilepsy may have a role in causing these unusual lesions. BMJ 1997;314: 1693. Letter.
10. Kälviäinen R, Äikiä M, Saukkonen AM, et al. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. Arch Neurol 1995;52:989-996.
11. Riekkinen P Sr., Äikiä M, Partanen K, Salmenperä T, Vainio P, Kälviäinen R. Efficacy and safety of vigabatrin monotherapy. Epilepsia 1997;38(suppl 8):104.
12. Gala'n F. Normal fields of vision with Goldmann perimetry. Bibl Ophtalmologica 1968;6:74.
13. Celesia GG, Bodis-Wollner I, Chatrian GE, Harding GFA, Sokol S, Spekreijse H. Recommended standards for electroretinograms and visual potentials. Report of an IFCN committee. Electroenceph Clin Neurophysiol 1993;87:421-436.
14. Butler WH, Ford GP, Newberne JW. A study of the effects of vigabatrin on the central nervous system and retina of Sprague-Dawley and Lister-Hooded rats. Toxicol Pathol 1987; 15:143-148.
15. Gibson JP, Yarrington JT, Loudy DE, Gerbig CG, Hurst GH, Newberne JW. Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor. Toxicol Pathol 1990;18:225-238.
16. Schroeder CE, Gibson JP, Yarrington J, Heydorn WE. Sussman NM, Arezzo JC. Effects of high dose gamma-vinyl-GABA (vigabatrin) administration on visual and somatosensory evoked potentials in dogs. Epilepsia 1992;33:S13-S25.
17. Jackson GD, Williams SR, van Bruggen N, Williams SCR, Duncan JS. Vigabatrin-induced lesions demonstrated by quantitative magnetic resonance imaging in the rat brain. Epilepsy Res 1994;18:57-66.
18. Cannon DJ, Butler WH, Mumford JP, Lewis PJ. Neuropathological findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy. J Child Neurol 1991; 6:17-24.
19. Mervaala E, Partanen J, Nousiainen U, Sivenius J, Riekkinen P. Electrophysiologic effects of gamma-vinyl GABA and carbamazepine. Epilepsia 1989;30:189-193.
20. Kälviäinen R, Äikiä M, Riekkinen PJ Sr. Cognitive effects of antiepileptic drugs. CNS Drugs 1996;5:358-368.